What a weekend. Such drama! Did Trump get oxygen or

New Post Public Reply Private Reply Replies (1) Message Board
Respert24
889
What a weekend. Such drama!

Did Trump get oxygen or not? What's he going to take? Did his doctor lie? Were those videos staged and taped before he got sicker? Did they really just parade him around the hospital "Weekend at Bernies" style?

It turns out the answer to that last question is no. He is alive and Sarah Sanders wasn't hiding just out of view shoving his arm back and forth while eating a burrito. Not sure why I think it was a burrito. She just seems like she likes a good burrito. Don't at me.

(Trigger Warning to those who are blindly Pro-Trump. Before getting to the why, this post will postulate some things you won't appreciate. I think these points are arguably true and the point isn't to just drag your guy but to help make a point about what Trump recovering from Covid does for Leronlimab and our country.)

So he didn't get Leronlimab but that was probably never going to happen unless he progressed. It sounds like, regardless of how bad it actually got, he never got dangerously bad. While that doesn't mean he's out of the woods completely, it appears for now that he will recover. That's good for him as I'm sure he wasn't interested in dying. It's actually good for us too.

Why? Well thank you for asking such a timely question. I was just about to answer it.

There were obviously a few ways his condition could go. Get better, get worse, or bounce around with symptoms until it broke one way or the other. If he were to get worse there's a chance that Leronlimab could have eventually found itself in the mix. But that didn't happen and it's still ok.

Why? Yeah, umm...I'm in the middle of answering that. Just hold on a second and I'll get there. Geez.

Trump gets the disease he has (arguably) treated like a hoax, that he has (arguably) failed to truly take seriously, that hasn't gone away despite already killing 200k+ Americans, and he has relatively easily come out on the other side of his personal experience with it saying we shouldn't be scared of it and proudly taking off his mask on camera.

That is very much not the same "no big deal" experience for the hundreds of thousands (perhaps millions) who have either died or spent a long time battling death before barely beating the virus. He's already taken the stance to his base that opening the country is the most important thing, that masks are for lesser folks, and that it's always just about to go away. Those who believe the same are now validated. That's not good for containing the virus.

This means that a not insignificant portion of our society will continue to not take this virus very seriously. For the same reason antivax folks have caused deadly diseases to show back up in our society, the segment of society that fervently follows Trump's lead will continue to do the same for the Coronavirus.

And if it doesn't go away, or doesn't go away as quickly as it could, that means that Leronlimab remains a very valuable drug in the near and long term. And that's just for Covid. I'm not even factoring in the other uses for CCR5 conditions.

To make my point more clear in case it already wasn't:

I think that Trump getting, and "relatively easily beating", Covid is going to lead to a strengthening of an already dangerous segment of today's Covid riddled society. Similar to anti-vax folks causing deadly diseases to come back in large numbers I think we will see large numbers of virus infections continue (leading to even more deaths) because a lot of people just had their dangerous, anti-science and anti-evidence viewpoint validated in their minds.

We (Trump lovers, Trump agnostics, and Trump haters who combine to make up this board of CYDY investors) remain in a very strong position to see our support of Leronlimab save lives in people infected with the Coronavirus as a result. Because it isn't going to go away anytime soon if our leader can't fully get behind doing what we need to do to destroy it.

(Fart Joke)

#TechnicalAnalysis

#ItWasTwoFiletMignonsButReallyItWasOneFatBoyiCutinHalfBeforeCooking
3

CytoDyn Inc (CYDY) Stock Research Links

CYDY Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

IASO's FUCASO Shows Robust Results in 2026 Study

Updated Category News Views 7

IASO's Groundbreaking Results Stir Ripples in Oncology Folks, let me paint the picture here with the mighty, nitty-gritty details straight from the heart of China. The 2026 IMS Annual Meeting held a gem that could redefine how investors see the course of hematologic malignancy treatments. IASO Bio dropped some heavy data, showing their fine product, FUCASO, in a...

Continue Reading
Leo Cancer Care's Upright Radiotherapy Milestone

Updated Category News Views 4

Upright Radiotherapy: Breaking Tradition in Cancer Care Here's a twist in the world of cancer treatment folks weren't exactly expecting. Leo Cancer Care has flipped the script by taking radiotherapy from a concept to an actual clinical reality with their Upright Platform. Yes, we're talking about standing up while getting treated, and it's not just a gimmick—it's a game...

Continue Reading
Accuray, Samsung Push Boundaries with Imaging Deal

Updated Category News Views 4

In a move that's got the healthcare industry buzzing, Accuray Incorporated (NASDAQ: ARAY) announced its partnership with Samsung NeuroLogica to supercharge the CyberKnife® System. This isn't just another collaboration; it's a strategic pivot to advance imaging capabilities, marrying Samsung's volumetric innovations with Accuray's established precision in robotic...

Continue Reading
AI Memory Growth Pushes Limits at GMIF2026 Summit

Updated Category News Views 4

The Memory and Storage Race in the AI Era The 5th GMIF2026 Innovation Summit wrapped up in Shenzhen, and boy, was it a heavyweight bout. You could practically feel the tension in the room as industry giants sparred over the future of memory and storage in AI. This wasn't just another trade show pow-wow; this was a strategic chess match over where AI infrastructure is...

Continue Reading
Fuse Oncology Showcases New iRT Workflow at ASTRO

Updated Category News Views 4

Revolutionizing Charge Capture in Oncology Fuse Oncology's latest showcase at the ASTRO 2026 Annual Meeting isn't just about flashy presentations—it's looking to change how radiation oncology departments handle complex workflows. If you've ever delved into the maze of oncology billing, you know it's rife with opportunities for errors and inefficiencies. Skip one charge,...

Continue Reading
Revamping Children's Radiotherapy: Leo Cancer Care's Vision

Updated Category News Views 5

The latest buzz in pediatric radiotherapy is shaking things up, and it’s all thanks to a game-changing shift in how treatment is delivered to kids. We're eyeballing Leo Cancer Care's innovative approach that might just redefine how these young patients face their battles. Standing Tall: A New Chapter in Proton Therapy In June, Stanford Medicine dished out the first...

Continue Reading
Melrose Fire Station Reaches Steel Topping Milestone

Updated Category News Views 4

Metal and Milestones: A New Era for Melrose Rolling into Melrose, Massachusetts, there's some serious action kicking off with the new Fire Engine 2 Station reaching a steel topping milestone. This phase isn't just about slapping on another beam; it's the crescendo of diligent teamwork from all the hands involved—from CTA Construction Managers to the clout of Ironworkers...

Continue Reading
Salveo Home Care Faces Class Action Over Labor Violations

Updated Category News Views 5

Another Company Lands in Hot Water Alright, it looks like Salveo Home Care is in the spotlight for all the wrong reasons. The home care provider—which should have been minding its P's and Q's—is now facing a class action suit. Why, you ask? Well, for allegedly skimping on wages and dodging legal obligations that leave their employees hanging dry. The Allegations are...

Continue Reading
DKS Facing Class Action Over Stock Slump Allegations

Updated Category News Views 3

A Burst Bubble at DICK'S Sporting Goods Grit your teeth and hang on—DICK'S Sporting Goods has stumbled, and investors are supposed to just weather the storm. From September 8, 2025, through August 24, 2026, if you held DICK'S shares, you've got some explaining to do, or at least you better start reading the fine print. Take note, folks: the deadline to file for lead...

Continue Reading
Quay Shines in 2026 Prescription Sunglasses Lineup

Updated Category News Views 5

Spotlight on Quay: A Fashion-Forward Prescription Glasses that make you look good and actually correct your vision? That's the holy grail right there. Consumer365 just put Quay front and center in their 2026 rundown of the best prescription sunglasses out there. Let's break this down and see what's got folks buzzing. Diving into Style and Substance Now, if you're like me,...

Continue Reading

Top 5 Most Recently Viewed Articles

Arqit Quantum Inc. Announces Upcoming FY 2025 Financial Call

Updated Category News Views 187

Arqit Quantum Inc. Conference Call Scheduled Arqit Quantum Inc., known for its pioneering advancements in quantum safe encryption, has made an important announcement regarding its financial reporting. The company will share its financial results for the fiscal year concluding on September 30, 2025, with stakeholders and interested parties. Date and Essential Details of...

Continue Reading
Premium Global Income Split Corp. Shares Financial Highlights

Updated Category News Views 203

Overview of Premium Global Income Split Corp. Premium Global Income Split Corp. operates as a mutual fund corporation that primarily invests in a diverse portfolio of large capitalization global equity securities. Known by its stock symbols, TSX: PGIC and PGIC.PR.A, the Fund focuses on enhancing income while reducing volatility through a series of strategic operations....

Continue Reading
Global Liquid Nitrogen Market Poised for Growth by 2033

Updated Category News Views 91

Overview of the Liquid Nitrogen Market The global liquid nitrogen market is anticipated to grow significantly, projected to reach an impressive value of USD 3,417.2 million by 2033. This growth represents a compound annual growth rate (CAGR) of 6.4% from its value of USD 1,960.6 million in 2024. Various factors, such as the rising demand for frozen foods and advancements...

Continue Reading
Hepsor AS Shows Growth in 2024 Annual Report Highlights

Updated Category News Views 323

Hepsor AS's 2024 Annual Report Overview The Management Board of Hepsor AS has meticulously prepared the audited annual report for 2024, which confirms that the audited financial results align with previously published unaudited figures, presenting a consistent picture for stakeholders. Financial Highlights In the 2024 financial year, Hepsor recorded a consolidated sales...

Continue Reading
Ethiopian Airlines Expands Fleet with Nine New 787s

Updated Category News Views 99

Ethiopian Airlines Expands Fleet with Nine New 787s Ethiopian Airlines, the largest carrier in Africa, has placed a significant order for nine Boeing 787 Dreamliners to enhance its capacity for long-haul travel. This move comes as the airline seeks to expand its international presence and cater to the growing demand for air travel across the globe. Strategic Expansion...

Continue Reading